ANDA 71961, held by Vpna. Sodium Nitroprusside.
As of Nov 16, 2026, ANDA 71961 (Nitropress), held by Vpna, was first approved by FDA on Aug 1, 1988, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 1, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nitropress25MG/ML · injectable;injection | Sodium Nitroprusside | Discontinued |
| Jan 27, 2014 | Supplement 13Labeling · Standard review | Approved | |
| Feb 10, 1995 | Supplement 4Manufacturing | Approved | |
| Feb 24, 1994 | Supplement 3Manufacturing | Approved | |
| Apr 9, 1992 | Supplement 2Labeling | Approved | |
| Jan 29, 1991 | Supplement 1Labeling | Approved | None posted |
| Aug 1, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters